gavel_istock-517976804_avosb-

Avosb / iStockphoto.com

24 October 2017Americas

Native American tribe hits back at Mylan in PTAB filing

The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Native American tribe seeks information on PTAB judges

4 January 2018 A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.

Tech companies have their say on Allergan-tribe deal at PTAB

4 December 2017 The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).

More on this story

Native American tribe seeks information on PTAB judges

4 January 2018 A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.

Tech companies have their say on Allergan-tribe deal at PTAB

4 December 2017 The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).

More on this story

Native American tribe seeks information on PTAB judges

4 January 2018 A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.

Tech companies have their say on Allergan-tribe deal at PTAB

4 December 2017 The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?